Clin2
NCT07548736Possibly a fitNot yet recruiting

Dexamethasone enema for rectal irritation after radiation therapy

Acute Radiation Enteritis

Treatments studied

Part of Cancer, Digestive system clinical trials.

This study tests whether giving a steroid medication (dexamethasone) as an enema can help reduce the side effect of radiation treatment on the rectal area. If you are getting radiation for rectal cancer and are bothered by rectal irritation, this might be a helpful addition to your care.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
40 people
Ages
18 years to 75 years
Study type
Interventional

Who can take part

  • You are between 18 and 75 years old.
  • You have been diagnosed with rectal cancer.
  • You are currently receiving standard radiation therapy to the pelvic area (a total dose of 40–50.4 Gy over 25–28 sessions).
  • You have not had radiation therapy to the pelvic area before.
  • Your overall health is reasonably good (able to care for yourself and expected to live more than 6 months).
  • You are not allergic to dexamethasone and are able to receive an enema.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07302126Not yet recruiting· Phase 2
Bergmann enema to prevent radiation injury in rectal cancer

This trial tests whether giving an enema (a liquid medicine inserted into the rectum) called Bergmann can help prevent rectal injury caused by radiation therapy in patients with rectal cancer. If you are about to start short-course radiation, this treatment might reduce side effects like pain or bleeding.

Guangzhou, Guangdong
NCT06776016Recruiting· Phase 2
Dietary supplement for radiation-related rectal injury

This trial tests a dietary supplement to help heal damage inside the rectum caused by pelvic radiation therapy. If you have mild to moderate rectal bleeding but no signs of cancer recurrence, you may be able to join.

Guangzhou, Guangdong
NCT07521605Not yet recruiting· Phase 2
Short course radiation and immunotherapy for rectal cancer

This trial tests a shorter radiation course combined with two chemotherapy drugs and an immunotherapy drug for people with locally advanced rectal cancer that is microsatellite stable. The goal is to shrink the tumor before surgery, which may improve outcomes with fewer side effects.

Guangzhou, Guangdong
NCT07802002Recruiting
Dietary supplement to prevent bowel injury during radiation for rectal cancer

This trial tests whether a special dietary supplement can help protect the rectum from radiation damage during chemoradiation for locally advanced rectal cancer. If it works, it may reduce painful bowel symptoms like frequent stools and cramping.

Guangzhou, Guangdong
NCT06410443Recruiting
Steroid treatment for radiation-induced bowel injury

This trial tests if local steroids can help heal bowel damage caused by radiation therapy for cancer. It may reduce pain, bleeding, and urgency, and improve quality of life.

Shenyang, Liaoning
NCT07065175Not yet recruiting· Phase 2
Liquid dressing for chronic radiation rectal injury

This study tests a liquid dressing that is applied to the rectum to help heal damage caused by radiation therapy. It may reduce bleeding, pain, and other symptoms of chronic radiation proctitis.

Beijing, Beijing Municipality

Hear when a new Acute Radiation Enteritis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.